Sight-Restoring Goggles

Pixium Vision's System Stimulates the Nervous System to Restore Vision

Pixium Vision is currently developing a revolutionary new implant and headpiece system called the 'Iris II' that is set to restore vision among people who have lost the ability to see. The goggles use a technique called "neuromodulation," which stimulates the nervous system with electricity from a chip in order to restore sight.

This system is set to provide a new kind of retinal implant that will help patients learn to see shapes in black, white and gray. As it stands, there are retinal implants capable of restoring sight, but the quality is not suited to responding to real-world conditions. Pixium Vision claims that it has been successful in restoring sight in rats at a level that's equivalent to 20/250.

Pixium Vision is now testing its vision system on patients in Europe who suffer from a variety of symptoms that can lead to blindness.

Neuromodulation Technology
The development of Pixium Vision's 'Iris II' system highlights the trend of using neuromodulation techniques to restore vision, creating opportunities for disruptive innovation in the field of sensory restoration.
Enhanced Retinal Implants
The focus on developing retinal implants with improved quality and responsiveness to real-world conditions presents disruptive innovation opportunities in the field of visual prosthetics.
Human Trials for Sight Restoration
The ongoing human trials conducted by Pixium Vision signify the trend of advancing research and development in restoring vision, opening up the potential for disruptive breakthroughs in the medical field.

Sectors Adopting This

Medical Devices
The development of Pixium Vision's sight-restoring goggles falls within the medical devices industry, which presents opportunities for disruptive innovation in sensory restoration technologies.
Biotechnology
The use of neuromodulation technology in Pixium Vision's system showcases the potential for disruptive innovation in the biotechnology industry, particularly in the field of vision restoration.
Medical Research
The human trials conducted by Pixium Vision highlight the importance of medical research in the quest for sight restoration, paving the way for disruptive innovation in the medical research industry.
SCORE
5.3 out of 10
GENDER
50% Men50% Women
MARKETTop markets: Europe
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 75%
Activity 75%
Freshness 8%

Solutions for innovators working at the edge of change. We help transform emerging ideas into practical, durable solutions by combining strategic thinking, creative exploration, and hands-on execution.

Trends © 2026 Trend Hunter Inc. All Rights Reserved.
LinkedIn Instagram X